Inova Schar Cancer Center

Fairfax, Virginia 22031

2 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, HER2-negative Breast Cancer, Head and Neck Cancer, Hearing Loss, Melanoma, Metastatic Breast Cancer, PIK3CA Mutation, Solid Tumor, Adult, Unresectable Solid Tumor

Studies at this site

• Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer — Recruiting now
• First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer — Recruiting now
• Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients — Stopped early